Prolactin receptor is a negative prognostic factor in patients with squamous cell carcinoma of the head and neck

@inproceedings{Bauernhofer2011ProlactinRI,
  title={Prolactin receptor is a negative prognostic factor in patients with squamous cell carcinoma of the head and neck},
  author={Thomas Bauernhofer and Martin Pichler and Eva U. Wieckowski and Joanna Stanson and Ariane Aigelsreiter and Antonia Griesbacher and Andrea Groselj-Strele and Alexander Linecker and Hellmut Samonigg and Cord Langner and Theresa L. Whiteside},
  booktitle={British Journal of Cancer},
  year={2011}
}
Background:The influence of human prolactin (hPRL) on the development of breast and other types of cancer is well established. Little information, however, exists on the effects of hPRL on squamous cell carcinomas of the head and neck (SCCHNs).Methods:In this study, we evaluated prolactin receptor (PRLR) expression in SCCHN cell lines and assessed by immunohistochemistry the expression in 89 patients with SCCHNs. The PRLR expression was correlated with clinicopathological characteristics as… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 43 REFERENCES

Prolactin--a novel neuroendocrine regulator of human keratin expression in situ.

  • Yuval Ramot, Tamás Bíró, +8 authors Ralf Paus
  • Medicine, Biology
  • FASEB journal : official publication of the Federation of American Societies for Experimental Biology
  • 2010
VIEW 1 EXCERPT

Serum prognostic markers in head and neck cancer.

VIEW 2 EXCERPTS